FDA okays Vertis' electrical pain relief device:
This article was originally published in Clinica
Vertis Neuroscience has gained US FDA 510(k) clearance to sell its non-surgical, minimally invasive electrical stimulation therapy to reduce pain and help rehabilitate patients suffering from low back pain. The Seattle, Washington-based firm said its PNT (percutaneous neuromodulation therapy) system can be used on an outpatient basis in the physician's office and is a cost-effective alternative or adjunct to conventional low back pain treatment. The device delivers electrical stimulation directly to the deep tissue surrounding the spine to alleviate persistent pain.